Foley Automotive Forum at the North American International Auto Show in Detroit
13 September 2023
Hosted alongside the 2023 North American International Auto Show, please join us for a half-day Automotive Forum on Wednesday, September 13, at the Detroit Athletic Club. The morning Forum will uncover critical areas spanning business and legal issues facing the automotive industry – including alternative powertrain technology, planning for the EV transition, potential impact of labor issues, and more. Detroit will be abuzz with a city-wide celebration of mobility, and this program will explore many of the issues and challenges facing our industry.
Featured Speakers
Pat StaarmannDirector of Sales for the Americas PHINIA |
Kurt NaglReporter Crain’s Detroit Business |
Steve WyboSenior Managing Director Riveron |
![]() Jon Gabriel Partner Foley & Lardner LLP |
Lynn GandhiPartner Foley & Lardner LLP |
Jeff KoppPartner Foley & Lardner LLP |
Vanessa MillerPartner Foley & Lardner LLP |
Felicia O’Connor |
Join us to learn about emerging trends across the industry. Register here. Secure your seat by September 11, 2023.
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…






